Abdel-Latif ME., Walker E., Osborn DA. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2024. 1:CD008309.
Article
Avery ME., Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959. 97(5, Part 1):517–23.
Article
Bae CW., Kim CY., Chung SH., Choi YS. History of pulmonary surfactant replacement therapy for neonatal respiratory distress syndrome in Korea. J Korean Med Sci. 2019. 34:e175.
Article
Bahadue FL., Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012. 11:CD001456.
Article
Choi HJ., Hahn S., Lee J., Park BJ., Lee SM., Kim HS., Bae CW, et al. Surfactant lavage therapy for meconium aspiration syndrome: a systematic review and meta-analysis. Neonatology. 2012. 101:183–91.
Article
Committee on Fetus and Newborn, American Academy of Pediatrics. Respiratory support in preterm infants at birth. Pediatrics. 2014. 133:171–4.
Dani C., Bertini G., Pezzati M., Cecchi A., Caviglioli C., Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks’ gestation. Pediatrics. 2004. 113:e560–3.
Dargaville PA., Aiyappan A., Cornelius A., Williams C., De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed. 2011. 96:F243–8.
Article
Dargaville PA., Aiyappan A., De Paoli AG., Dalton RG., Kuschel CA., Kamlin CO, et al. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences. Neonatology. 2013. 104:8–14.
Article
El Shahed AI., Dargaville P., Ohlsson A., Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev. 2007. 3:CD002054.
Article
European Exosurf Study Group. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. Online J Curr Clin Trials. 1992. Doc No 28:[3886 words; 47 paragraphs].
Finer NN., Carlo WA., Walsh MC., Rich W., Gantz MG., Laptook AR, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010. 362:1970–9.
Article
Fuchs H., Lindner W., Leiprecht A., Mendler MR., Hummler HD. Predictors of early nasal CPAP failure and effects of various intubation criteria on the rate of mechanical ventilation in preterm infants of <29 weeks gestational age. Arch Dis Child Fetal Neonatal Ed. 2011. 96:F343–7.
Article
Fujiwara T., Maeta H., Chida S., Morita T., Watabe Y., Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980. 1:55–9.
Article
Gruenwald P. Surface tension as a factor in the resistance of neonatal lungs to aeration. Am J Obstet Gynecol. 1947. 53:996–1007.
Article
Hallman M., Herting E. Historical perspective on surfactant therapy: transforming hyaline membrane disease to respiratory distress syndrome. Semin Fetal Neonatal Med. 2023. 28:101493.
Article
Hillman N., Jobe AH. Noninvasive strategies for management of respiratory problems in neonates. Neoreviews. 2013. 14:e227–36.
Article
Hong CY., Ahn HS., Young SH. Pediatrics. 12th ed. Seoul (Korea): Mirae N;2020.
Isayama T., Iwami H., McDonald S., Beyene J. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and metaanalysis. JAMA. 2016. 316:611–24.
Article
Jeon GW. Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future. Korean J Pediatr. 2019. 62:155–61.
Article
Jeon GW., Lee JH., Oh M., Chang YS. Serial short-term outcomes of very-low-birth-weight infants in the Korean Neonatal Network from 2013 to 2020. J Korean Med Sci. 2022. 37:e229.
Article
Kanmaz HG., Erdeve O., Canpolat FE., Mutlu B., Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013. 131:e502–9.
Article
Kesler H., Lohmeier K., Hoehn T., Kribs A., Peinemann F. Thincatheter surfactant application for respiratory distress syndrome in spontaneously breathing preterm infants: a meta-analysis of randomized clinical trials. Curr Pediatr Rev. 2022. 18:286–300.
Klebermass-Schrehof K., Wald M., Schwindt J., Grill A., Prusa AR., Haiden N, et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology. 2013. 103:252–8.
Article
Kolatat T., Aunganon K., Yosthiem P. Airway complications in neonates who received mechanical ventilation. J Med Assoc Thai. 2002. 85(Suppl 2):S455–62.
Kribs A., Pillekamp F., Hünseler C., Vierzig A., Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age </=27 weeks). Paediatr Anaesth. 2007. 17:364–9.
Ma CC., Ma S. The role of surfactant in respiratory distress syndrome. Open Respir Med J. 2012. 6:44–53.
Article
Morley CJ., Davis PG., Doyle LW., Brion LP., Hascoet JM., Carlin JB. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008. 358:700–8.
Article
Ng EH., Shah V. Guidelines for surfactant replacement therapy in neonates. Paediatr Child Health. 2021. 26:35–49.
Article
Plavka R., Kopecký P., Sebron V., Leiská A., Svihovec P., Ruffer J, et al. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation. Intensive Care Med. 2002. 28:1483–90.
Article
Polin RA., Carlo WA. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014. 133:156–63.
Article
Ramaswamy VV., More K., Roehr CC., Bandiya P., Nangia S. Efficacy of noninvasive respiratory support modes for primary respiratory support in preterm neonates with respiratory distress syndrome: Systematic review and network meta-analysis. Pediatr Pulmonol. 2020. 55:2940–63.
Article
Rojas MA., Lozano JM., Rojas MX., Laughon M., Bose CL., Rondon MA, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics. 2009. 123:137–42.
Article
Rojas-Reyes MX., Morley CJ., Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012. 3:CD000510.
Article
Shim GH. Update of minimally invasive surfactant therapy. Korean J Pediatr. 2017. 60:273–81.
Article
Shin JE., Yoon SJ., Lim J., Han J., Eun HS., Park MS, et al. Pulmonary surfactant replacement therapy for respiratory distress syndrome in neonates: a nationwide epidemiological study in Korea. J Korean Med Sci. 2020. 35:e253.
Article
Silveira RC., Panceri C., Munõz NP., Carvalho MB., Fraga AC., Procianoy RS. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: a systematic review and meta-analyses. J Pediatr (Rio J). 2024. 100:8–24.
Article
Soll RF., Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001. 2:CD000510.
Article
Stevens TP., Harrington EW., Blennow M., Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007. 2007:CD003063.
Article
Sweet DG., Carnielli VP., Greisen G., Hallman M., Klebermass-Schrehof K., Ozek E, et al. European Consensus Guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023. 120:3–23.
Article
Sweet DG., Carnielli V., Greisen G., Hallman M., Ozek E., Plavka R, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 update. Neonatology. 2013. 103:353–68.
Article
Sweet DG., Carnielli V., Greisen G., Hallman M., Ozek E., Te Pas A, et al. European Consensus Guidelines on the management of respiratory distress syndrome-2019 update. Neonatology. 2019. 115:432–50.
Article
Venkatesh V., Ponnusamy V., Anandaraj J., Chaudhary R., Malviya M., Clarke P, et al. Endotracheal intubation in a neonatal population remains associated with a high risk of adverse events. Eur J Pediatr. 2011. 170:223–7.
Article
Verder H., Albertsen P., Ebbesen F., Greisen G., Robertson B., Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation. Pediatrics. 1999. 103:E24.
Article